IPCI
IntelliPharmaCeutics International Inc.

5,621
Loading...
Loading...
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Intellipharmaceutics International Inc?
What is the 52-week high for Intellipharmaceutics International Inc?
What is the 52-week low for Intellipharmaceutics International Inc?
What is the 50-day moving average of Intellipharmaceutics International Inc?

Latest IPCI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.